Mosaic stock has fallen about 39.6% over the past three years, yet both the earnings multiples and a Discounted Cash Flow (DCF) intrinsic value estimate currently point to the shares trading at a discount to what the underlying cash flows may justify.
The issue now is whether Mosaic's current discount to intrinsic value and multiples offers enough margin of safety given the recent share price performance and the risks around fertilizer economics.
Find out why Mosaic's -36.7% return over the last year is lagging behind its peers.
The Discounted Cash Flow (DCF) model estimates what Mosaic’s future cash flows could be worth in today’s dollars. For Mosaic, the latest twelve month free cash flow is reported as a loss of about $502 million, so the model is effectively assuming that cash generation recovers from this weak base and trends toward steady, positive free cash flow over time.
On those assumptions, the DCF points to an estimated intrinsic value of about $40.58 per share, implying the stock is 45.9% undervalued relative to the current price. The recent 3.7% share price move higher after the US Department of Agriculture’s US$500 million fertilizer expansion commitment helps explain some renewed interest in Mosaic, although the shares are still priced below what the model suggests its cash flows could support.
Overall, the Discounted Cash Flow workup indicates Mosaic stock appears undervalued at current levels.
Our Discounted Cash Flow (DCF) analysis suggests Mosaic is undervalued by 45.9%. Track this in your watchlist or portfolio, or discover 50 more high quality undervalued stocks.
P/S can be a useful lens for Mosaic because revenue can often be less volatile than earnings in a cyclical chemicals business. Mosaic trades on a P/S ratio of about 0.6x, compared with an industry average of roughly 1.1x and a peer average near 1.3x. As a result, the stock changes hands at a sizeable discount to sector sales multiples.
The fair P/S ratio implied by Simply Wall St's model is around 0.9x, which blends Mosaic's revenue profile, margins, size, and risk into a tailored benchmark. Against that yardstick, the current 0.6x suggests the market is assigning a lower value to each dollar of Mosaic's sales than the model would imply, even after taking those risk factors into account.
On this P/S framework, Mosaic stock appears undervalued compared with what its revenue base might justify.
See what the numbers say about this price — find out in our valuation breakdown.
Simply Wall St Narratives for Mosaic pick up where the valuation work leaves off by spelling out which paths for Mosaic's revenue, margins and earnings would make the stock worth significantly more or less than today’s price on the Community page.
Each narrative ties its numbers to a specific view on how Mosaic's growth, profitability and risks evolve, giving you a concrete set of assumptions you can revisit as new information on the company arrives.
Community views on Mosaic sit far apart, with one side focused on margin recovery potential and the other worried about a structural reset in fertilizer economics.
Bull case: 37% undervalued
"Mosaic's leadership in advanced fertilizer solutions, particularly through Mosaic Biosciences, positions it to capitalize on the accelerating shift toward precision agriculture and higher-value specialty products..."
Read the full Bull Case to see why Mosaic could be undervalued
Bear case: 10% overvalued
"Rapid advancements in precision agriculture and alternative nutrient technologies threaten to undermine long-term demand for Mosaic's traditional phosphate and potash products..."
Read the full Bear Case to see why Mosaic could be overvalued
Do you think there's more to the story for Mosaic? Head over to our Community to see what others are saying!
For Mosaic, both the Discounted Cash Flow (DCF) intrinsic value estimate and the sales multiple view currently point to the stock as undervalued rather than obviously expensive or fair. The broader valuation checks line up in the same direction, so the main question is not whether Mosaic is cheap on paper, but whether that discount is compensation for real risk in fertilizer economics and cash generation.
What matters most from here is whether Mosaic can sustain healthier, more predictable margins and free cash flow in a changing fertilizer market, so the current discount either closes or proves to be a value trap.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com